BackSOPHiA Genetics SA Overview
SOPHiA Genetics SA

SOPHiA Genetics SA Target Price

Where could SOPH trade next? Consensus target price: $12.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.38

Average Target Price

$11.6758.1% upside

3 analysts in the last 4 months

High: $14 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-05BTIGMark Massaro$922% upsideOpen
2026-08-05H.C. WainwrightSwayampakula Ramakanth$1489.7% upsideOpen
2026-07-20H.C. Wainwright$1262.6% upsideOpen
2026-04-15BTIG$88.4% upsideOpen
2026-03-03BTIGMark Massaro$75.1% downsideOpen
2026-01-26Guggenheim$75.1% downsideOpen
2025-03-06BTIG$532.2% downsideOpen
2024-08-07Morgan StanleyTejas Savant$532.2% downsideOpen
2024-06-27GuggenheimSubbu Nambi$618.7% downsideOpen
2023-01-03BTIGMark Massaro$618.7% downsideOpen

SOPHiA Genetics SA (SOPH) FAQ

The latest target price for SOPH is $12. Investors often review this figure alongside SOPHiA Genetics SA's historical trend and sector peers before judging valuation or financial health.

SOPHiA Genetics SA trades near $7.38 while the consensus target sits at $12 (58.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting SOPH's target price ($12), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack SOPHiA Genetics SA's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.